Third Harmonic Bio Inc. (THRD)
Healthcare
Biotechnology
5.40 $
+0.0%
vs. previous close
Closing price · As of: 2. Jul 2026
Who owns Third Harmonic Bio Inc. (THRD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 34.6% of the shares are freely tradable; institutional investors hold 80.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
80.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
9.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
34.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
5.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
45Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Orbimed Advisors, LLC | 12.81 | 5,779,071 | +0.0 | 06/30/2025 |
| BML Capital Management LLC | 8.47 | 3,824,417 | +0.0 | 06/30/2025 |
| Nantahala Capital Management, LLC | 6.51 | 2,938,700 | +0.0 | 06/30/2025 |
| TCG Crossover Management, LLC | 4.24 | 1,915,424 | -23.5 | 06/30/2025 |
| BlackRock Inc | 3.83 | 1,726,614 | +16.7 | 06/30/2025 |
| Vanguard Group Inc | 2.88 | 1,298,089 | +11.9 | 06/30/2025 |
| D. E. Shaw & Co LP | 2.77 | 1,250,680 | +118.1 | 06/30/2025 |
| TANG CAPITAL MANAGEMENT LLC | 2.06 | 929,727 | +0.0 | 06/30/2025 |
| Schonfeld Strategic Advisors LLC | 1.71 | 770,800 | +2,460.3 | 06/30/2025 |
| ADAR1 Capital Management LLC | 1.38 | 622,873 | +522.9 | 06/30/2025 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.